vs

Side-by-side financial comparison of MITEK SYSTEMS INC (MITK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $44.2M, roughly 1.7× MITEK SYSTEMS INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 18.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $6.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -2.9%).

Mitek Systems, Inc. is a software company that specializes in digital identity verification and mobile image processing using artificial intelligence. The company's software is used for depositing checks and opening bank accounts via mobile devices. It also verifies identity documents such as passports, ID cards, and driver's licenses by analyzing a selfie of an individual holding their ID, comparing their face to the photo on the document.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

MITK vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.7× larger
PBYI
$75.5M
$44.2M
MITK
Growing faster (revenue YoY)
PBYI
PBYI
+9.0% gap
PBYI
27.7%
18.8%
MITK
More free cash flow
PBYI
PBYI
$7.8M more FCF
PBYI
$14.4M
$6.6M
MITK
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-2.9%
MITK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MITK
MITK
PBYI
PBYI
Revenue
$44.2M
$75.5M
Net Profit
$2.8M
Gross Margin
69.3%
Operating Margin
12.3%
22.7%
Net Margin
6.3%
Revenue YoY
18.8%
27.7%
Net Profit YoY
160.1%
EPS (diluted)
$0.06
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MITK
MITK
PBYI
PBYI
Q4 25
$44.2M
$75.5M
Q3 25
$44.8M
$54.5M
Q2 25
$45.7M
$52.4M
Q1 25
$51.9M
$46.0M
Q4 24
$37.3M
$59.1M
Q3 24
$43.2M
$80.5M
Q2 24
$45.0M
$47.1M
Q1 24
$47.0M
$43.8M
Net Profit
MITK
MITK
PBYI
PBYI
Q4 25
$2.8M
Q3 25
$1.9M
$8.8M
Q2 25
$2.4M
$5.9M
Q1 25
$9.2M
$3.0M
Q4 24
$-4.6M
Q3 24
$8.6M
$20.3M
Q2 24
$216.0K
$-4.5M
Q1 24
$282.0K
$-4.8M
Gross Margin
MITK
MITK
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
MITK
MITK
PBYI
PBYI
Q4 25
12.3%
22.7%
Q3 25
10.5%
17.6%
Q2 25
8.3%
12.7%
Q1 25
21.9%
8.7%
Q4 24
-8.3%
22.6%
Q3 24
17.8%
27.4%
Q2 24
1.6%
-4.6%
Q1 24
1.5%
-5.3%
Net Margin
MITK
MITK
PBYI
PBYI
Q4 25
6.3%
Q3 25
4.2%
16.2%
Q2 25
5.2%
11.2%
Q1 25
17.6%
6.5%
Q4 24
-12.4%
Q3 24
19.8%
25.2%
Q2 24
0.5%
-9.6%
Q1 24
0.6%
-11.0%
EPS (diluted)
MITK
MITK
PBYI
PBYI
Q4 25
$0.06
$0.26
Q3 25
$0.04
$0.17
Q2 25
$0.05
$0.12
Q1 25
$0.20
$0.06
Q4 24
$-0.10
$0.40
Q3 24
$0.19
$0.41
Q2 24
$0.00
$-0.09
Q1 24
$0.01
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MITK
MITK
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$190.1M
$97.5M
Total DebtLower is stronger
$4.8M
$22.7M
Stockholders' EquityBook value
$233.7M
$130.3M
Total Assets
$446.5M
$216.3M
Debt / EquityLower = less leverage
0.02×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MITK
MITK
PBYI
PBYI
Q4 25
$190.1M
$97.5M
Q3 25
$193.0M
$94.4M
Q2 25
$167.1M
$96.0M
Q1 25
$136.2M
$93.2M
Q4 24
$121.2M
$101.0M
Q3 24
$130.3M
$96.7M
Q2 24
$123.1M
$96.8M
Q1 24
$123.9M
$107.2M
Total Debt
MITK
MITK
PBYI
PBYI
Q4 25
$4.8M
$22.7M
Q3 25
$4.3M
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$2.7M
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
MITK
MITK
PBYI
PBYI
Q4 25
$233.7M
$130.3M
Q3 25
$240.3M
$115.3M
Q2 25
$237.6M
$104.7M
Q1 25
$220.2M
$97.1M
Q4 24
$200.9M
$92.1M
Q3 24
$214.8M
$71.1M
Q2 24
$209.6M
$48.5M
Q1 24
$216.1M
$51.0M
Total Assets
MITK
MITK
PBYI
PBYI
Q4 25
$446.5M
$216.3M
Q3 25
$459.1M
$202.9M
Q2 25
$446.7M
$194.9M
Q1 25
$425.3M
$196.2M
Q4 24
$396.0M
$213.3M
Q3 24
$413.8M
$220.7M
Q2 24
$409.2M
$205.0M
Q1 24
$417.0M
$214.1M
Debt / Equity
MITK
MITK
PBYI
PBYI
Q4 25
0.02×
0.17×
Q3 25
0.02×
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
0.01×
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MITK
MITK
PBYI
PBYI
Operating Cash FlowLast quarter
$8.0M
$14.4M
Free Cash FlowOCF − Capex
$6.6M
$14.4M
FCF MarginFCF / Revenue
14.9%
19.1%
Capex IntensityCapex / Revenue
3.2%
0.0%
Cash ConversionOCF / Net Profit
2.89×
TTM Free Cash FlowTrailing 4 quarters
$60.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MITK
MITK
PBYI
PBYI
Q4 25
$8.0M
$14.4M
Q3 25
$19.5M
$9.7M
Q2 25
$21.6M
$14.1M
Q1 25
$13.7M
$3.6M
Q4 24
$565.0K
$15.6M
Q3 24
$21.1M
$11.0M
Q2 24
$13.0M
$1.0M
Q1 24
$7.1M
$11.2M
Free Cash Flow
MITK
MITK
PBYI
PBYI
Q4 25
$6.6M
$14.4M
Q3 25
$19.2M
$9.7M
Q2 25
$21.2M
$14.1M
Q1 25
$13.5M
$3.6M
Q4 24
$230.0K
$15.6M
Q3 24
$20.8M
$11.0M
Q2 24
$12.6M
$1.0M
Q1 24
$6.6M
FCF Margin
MITK
MITK
PBYI
PBYI
Q4 25
14.9%
19.1%
Q3 25
42.9%
17.7%
Q2 25
46.5%
26.8%
Q1 25
26.0%
7.7%
Q4 24
0.6%
26.4%
Q3 24
48.2%
13.7%
Q2 24
27.9%
2.1%
Q1 24
14.0%
Capex Intensity
MITK
MITK
PBYI
PBYI
Q4 25
3.2%
0.0%
Q3 25
0.6%
0.0%
Q2 25
0.7%
0.0%
Q1 25
0.4%
0.1%
Q4 24
0.9%
0.0%
Q3 24
0.7%
0.0%
Q2 24
1.0%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
MITK
MITK
PBYI
PBYI
Q4 25
2.89×
Q3 25
10.46×
1.10×
Q2 25
9.00×
2.41×
Q1 25
1.50×
1.21×
Q4 24
Q3 24
2.46×
0.54×
Q2 24
60.12×
Q1 24
25.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MITK
MITK

Fraud And Identity Solutions$25.5M58%
License$13.9M31%
Fraud And Identity Solutions Software License And Support$3.9M9%
Professional Services And Other$1.2M3%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons